Skip to content

Transform Genomic Data into Research-ready Delivery

Get Started

Drug discovery programs stall when critical genomic datasets are difficult to source. Population health studies struggle when cohort diversity doesn’t match the research question. Diagnostic innovators lose valuable time navigating fragmented data pipelines before they can even begin model development.

We bring together ~500,000 population-scale genomic samples in a centralized, pre-analyzed data environment. This enables us to empower pharma, biotech, CROs, diagnostics companies, and academic research teams with a faster path from data discovery to scientific insight.

Discover. Validate. Procure. Accelerate.

Scientist examining a sample in a drug discovery laboratory
Researchers reviewing genomic data in a data centre

Built for the Pioneers Who Cannot Wait

Curated Datasets at Population Scale01

Curated Datasets at Population Scale

Access pre-analyzed genome data spanning approximately 500,000 samples, organized for rapid cohort identification and downstream research.

02

Self-service Exploration

Browse, filter, and evaluate datasets by disease area, demographic profile, sample type, and genomic markers. No intermediaries.

03

Research-ready Formats

Every dataset ships with the documentation, quality annotations, and metadata that your research teams need to begin analysis immediately.

Flexible, Requirements-driven Data Acquisition04

Flexible, Requirements-driven Data Acquisition

Define your target cohort, genomic attributes, population characteristics, sample size, and other study-specific requirements.

Researchers at work in a genomics laboratory

Designed for Discovery-stage Decision Makers

Pharmaceutical & Biotech R&D

Accelerate target discovery and drug candidature validation with population-scale genomic evidence. Source cohorts by disease, demographics, and molecular markers from one platform.

Contract Research Organizations (CROs)

Reduce study startup timelines by sourcing protocol-matched genomic data at scale, without directly managing biobank relationships.

Academic & Research Institutions

Run population genetic studies, epidemiological analyses, and translational research on ready-to-use genomic datasets. No infrastructure investment is required.

Diagnostic & IVD Companies

Train AI models, benchmark assays, and build regulatory evidence packages using diverse, well-annotated genomic data at population scale.

Payers

Apply genomic outcomes data to patient stratification and coverage decisions — linking population-scale evidence directly to health economics.

The Rohtek Factor

Genomic data streams converging through a series of lenses
01

Scale That Matches Real-world Research Needs

Approximately, 500,000 population-level samples – sufficient for oncology & rare-variant discovery, stratified subgroup analyses, and cross-population comparisons.

02

Speed Without Sacrifice

No months long procurement cycles. Explore our catalog, identify relevant datasets, and complete the acquisition through a single, streamlined digital workflow.

03

Domain Expertise Embedded in the Platform

Decades of combined experience across clinical genomics, data engineering, and life sciences AI, built into every platform decision.

04

A Future-first Roadmap

Beyond data commerce, self-service analytics and real-world clinical data integration are already on our product roadmap.

Your Next Discovery
Starts with the Right Data

Talk to Our Experts
Scroll to Top